Clinical Trial Update: SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in ES-SCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SHR-1316 with chemotherapy and chest radiotherapy for extensive-stage small cell lung cancer, currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• SHR-1316

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING